Form 8-K - Current report:
SEC Accession No. 0000950170-24-114467
Filing Date
2024-10-15
Accepted
2024-10-15 08:00:08
Documents
11
Period of Report
2024-10-09
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K itrm-20241009.htm   iXBRL 8-K 39177
  Complete submission text file 0000950170-24-114467.txt   157256

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itrm-20241009.xsd EX-101.SCH 26763
13 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20241009_htm.xml XML 4891
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 241369333
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)